Option Care Health (NASDAQ:OPCH) Lowered to “Hold” Rating by Stephens

Option Care Health (NASDAQ:OPCH) was downgraded by stock analysts at Stephens from a “strong-buy” rating to a “hold” rating in a report issued on Friday,Zacks.com reports.

Other equities research analysts have also recently issued research reports about the company. TD Cowen decreased their price objective on Option Care Health from $37.00 to $23.00 and set a “hold” rating on the stock in a report on Friday, May 1st. Barrington Research dropped their target price on Option Care Health from $42.00 to $32.00 and set an “outperform” rating for the company in a research note on Friday, May 1st. The Goldman Sachs Group started coverage on Option Care Health in a research report on Monday, June 8th. They set a “neutral” rating and a $22.00 target price on the stock. Truist Financial set a $30.00 price target on Option Care Health in a research note on Friday, May 1st. Finally, UBS Group restated a “buy” rating on shares of Option Care Health in a report on Tuesday, June 16th. Eight investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, Option Care Health has an average rating of “Moderate Buy” and a consensus target price of $30.08.

Option Care Health Stock Down 1.6%

Shares of NASDAQ OPCH opened at $21.74 on Friday. Option Care Health has a 1 year low of $18.01 and a 1 year high of $36.80. The firm’s 50 day moving average price is $21.15 and its 200 day moving average price is $27.50. The firm has a market cap of $3.41 billion, a P/E ratio of 16.85, a price-to-earnings-growth ratio of 1.23 and a beta of 0.65. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.07 and a current ratio of 1.64.

Option Care Health (NASDAQ:OPCH) last released its earnings results on Thursday, April 30th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.37 by $0.03. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.39 billion. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. Option Care Health’s revenue for the quarter was up 1.3% on a year-over-year basis. During the same period in the previous year, the company earned $0.40 EPS. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. As a group, sell-side analysts anticipate that Option Care Health will post 1.64 earnings per share for the current year.

Insider Activity

In other news, CEO John Charles Rademacher bought 12,500 shares of the business’s stock in a transaction that occurred on Monday, May 4th. The shares were acquired at an average cost of $21.18 per share, with a total value of $264,750.00. Following the transaction, the chief executive officer owned 695,152 shares of the company’s stock, valued at $14,723,319.36. This represents a 1.83% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Timothy P. Sullivan bought 24,154 shares of Option Care Health stock in a transaction that occurred on Thursday, May 7th. The stock was purchased at an average price of $20.69 per share, for a total transaction of $499,746.26. Following the acquisition, the director directly owned 73,383 shares of the company’s stock, valued at $1,518,294.27. The trade was a 49.06% increase in their position. The SEC filing for this purchase provides additional information. Insiders purchased 73,264 shares of company stock valued at $1,548,316 in the last ninety days. Company insiders own 1.70% of the company’s stock.

Institutional Investors Weigh In On Option Care Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Wedge Capital Management L L P NC raised its holdings in shares of Option Care Health by 25.7% in the 2nd quarter. Wedge Capital Management L L P NC now owns 190,257 shares of the company’s stock worth $3,990,000 after purchasing an additional 38,856 shares during the period. Harbor Investment Advisory LLC purchased a new stake in shares of Option Care Health during the 2nd quarter worth about $48,000. Central Pacific Bank Trust Division grew its holdings in shares of Option Care Health by 18.9% during the 2nd quarter. Central Pacific Bank Trust Division now owns 13,829 shares of the company’s stock worth $290,000 after purchasing an additional 2,200 shares during the period. Pacer Advisors Inc. increased its position in Option Care Health by 1.3% during the 1st quarter. Pacer Advisors Inc. now owns 42,649 shares of the company’s stock worth $1,148,000 after purchasing an additional 528 shares in the last quarter. Finally, Summitry LLC acquired a new stake in Option Care Health during the 1st quarter worth approximately $200,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.